47 results
Keyword Ipilimumab Remove keyword
-
List item
Press release: New treatment option recommended for patients with advanced melanoma
CHMP, Last updated: 22/05/2015other comparing Keytruda with ipilimumab, another melanoma treatment … had not previously received ipilimumab and in patients who had previously … had previously received ipilimumab. The Committee also looked … -
List item
National expert: Mark van Bussel, Medicines Evaluation Board (updated)
- Declaration of interests - 79.03 KB | PDF
- Curriculum Vitae - 58.48 KB | PDF
responses of nivolumab and ipilimumab: a pharmacodynamic and pharmacokinetic … -
List item
National expert: Birgit Geoerger, European Medicines Agency (updated)
- Declaration of interests - 81.31 KB | PDF
- Curriculum Vitae - 71.5 KB | PDF
ridaforolimus, dabrafenib, ipilimumab, LDK378, LEE011, abraxane … -
List item
Press release: European Medicines Agency recommends approval of Tafinlar for the treatment of metastatic melanoma
CHMP, Last updated: 28/06/2013them, the monoclonal antibody ipilimumab, targets a molecule found … them, the monoclonal antibody ipilimumab, targets a molecule found … -
List item
National expert: Aranzazu Sancho-Lopez, Spanish Agency of Medicines and Medical Devices (updated)
- Declaration of interests - 81.17 KB | PDF
- Curriculum Vitae - 82.78 KB | PDF
medicines Agency review of ipilimumab (Yervoy) for the treatment … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 November 2018
CHMP, Last updated: 16/11/2018ipilimumab) in combination to treat … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 February 2020
CHMP, Last updated: 28/02/2020ipilimumab) in the treatment of metastatic … -
List item
National expert: Daniela Cianci, Medicines Evaluation Board (updated)
- Declaration of interests - 81.1 KB | PDF
- Curriculum Vitae - 69.73 KB | PDF
Nivolumab, Ipilimumab BMS CASSIOPEIA … -
List item
National expert: Nuno Sousa, National Authority of Medicines and Health Products, I.P. (updated)
- Declaration of interests - 84.51 KB | PDF
- Curriculum Vitae - 56.11 KB | PDF
09/2017-(current) Bristol-Myers Squibb Ipilimumab Metastatic Gastric Cancer … -
List item
National expert: Kyrre Eeg Emblem, European Medicines Agency (updated)
- Declaration of interests - 81.1 KB | PDF
- Curriculum Vitae - 124.09 KB | PDF
-
List item
Press release: European Medicines Agency recommends approval of Mekinist for the treatment of melanoma
CHMP, Last updated: 25/04/2014a monoclonal antibody (ipilimumab) that targets a molecule … including a monoclonal antibody (ipilimumab) that targets a molecule … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 September 2018
CHMP, Last updated: 21/09/2018ipilimumab) have requested re-examination … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 July 2018
CHMP, Last updated: 27/07/2018ipilimumab) in combination to treat … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 April 2018
CHMP, Last updated: 27/04/2018Name of medicine Yervoy INN ipilimumab Marketing-authorisation holder … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 December 2017
CHMP, Last updated: 15/12/2017Name of medicine Yervoy INN ipilimumab Marketing-authorisation holder … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 September 2013
CHMP, Last updated: 20/09/2013Yervoy INN ipilimumab Marketing-authorisation holder … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 May 2011
CHMP, Last updated: 20/05/2011210 days. • Yervoy (ipilimumab), from Bristol-Myers Squibb … ipilimumab), from Bristol-Myers Squibb … -
List item
National expert: Patrick Schöffski, European Medicines Agency (updated)
- Declaration of interests - 82.26 KB | PDF
- Curriculum Vitae - 202.22 KB | PDF
with combined nivolumab and ipilimumab in advanced melanoma. N Engl … -
List item
PRAC recommendations on safety signals
Last updated: 23/06/2020 -
List item
Scientific publications (updated)
Last updated: 30/07/2020 -
List item
Newsletters (updated)
Last updated: 17/07/2020 -
List item
PDCO: Agendas, minutes and meeting reports
Last updated: 27/01/2020 -
List item
PRAC: Agendas, minutes and highlights
Last updated: 14/06/2019 -
List item
Annual reports and work programmes
Last updated: 15/06/2020 -
List item
Class waivers
Last updated: 28/05/2018